Physicians need further education to fully understand and implement current advanced therapies and distinguish the pathways of disease and targets addressed by newer therapies. This educational activity will provide key clinical data on new and emerging treatments, focusing on the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in the context of evolving understanding of disease immunopathogenesis.
modules

Webcast
0.25 AMA PRA
Trends and Updates in IBD: Appraising the Therapeutic Armamentarium in Moderate and Severe Disease

Webcast
0.25 AMA PRA